| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $7.8M | — |
| SG&A Expense | $6.2M | — |
| Operating Income | -$14.0M | — |
| Pre-tax Income | -$13.6M | — |
| Income Tax | $28K | — |
| Net Income | -$13.7M | — |
| EPS (Basic) | -$0.52 | — |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | -70.8% |
| Short-term Investments | $28.8M | -9.7% |
| Accounts Receivable | $82K | -21.2% |
| Current Assets | $33.8M | -30.3% |
| Total Assets | $34.4M | -29.3% |
| Current Liabilities | $2.2M | +33.5% |
| Stockholders' Equity | $31.8M | -32.3% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.5M | — |
| Capital Expenditures | $81K | — |
| Investing Cash Flow | $11.5M | — |
| Financing Cash Flow | -$6K | — |
| Free Cash Flow | -$11.6M | — |